Trial Profile
Treatment with cabergoline in patients with ACTH-dependent Cushing´s syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Mar 2016
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary)
- Indications Pituitary ACTH hypersecretion
- Focus Therapeutic Use
- 17 Mar 2016 New trial record